OTCMKTS:AOBI - American Oriental Bioengineering Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.50 0.00 (0.00 %)
(As of 09/20/2018 05:33 AM ET)
Previous Close$2.50
Today's Range$2.50 - $2.50
52-Week Range$1.15 - $2.50
Volume3 shs
Average Volume2 shs
Market Capitalization$180,000.00
P/E RatioN/A
Dividend YieldN/A
American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

Receive AOBI News and Ratings via Email

Sign-up to receive the latest news and ratings for AOBI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares70,000
Market Cap$180,000.00

American Oriental Bioengineering (OTCMKTS:AOBI) Frequently Asked Questions

What is American Oriental Bioengineering's stock symbol?

American Oriental Bioengineering trades on the OTCMKTS under the ticker symbol "AOBI."

Who are some of American Oriental Bioengineering's key competitors?

Who are American Oriental Bioengineering's key executives?

American Oriental Bioengineering's management team includes the folowing people:
  • Mr. Shujun Liu, Founder, Chairman, Chief Exec. Officer and Pres (Age 65)
  • Ms. Yanchun Li, Founder, Chief Financial Officer, Sec. and Director (Age 49)
  • Mr. Jun Min, Founder, VP, Gen. Mang. of HSPL and Director (Age 59)
  • Mr. Xiaopeng Xu, Chief Operating Officer (Age 69)
  • Mr. Lawrence S. Wizel, Financial Consultant (Age 75)

Has American Oriental Bioengineering been receiving favorable news coverage?

News coverage about AOBI stock has trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. American Oriental Bioengineering earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news headlines about the company an impact score of 46.57 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for American Oriental Bioengineering.

How do I buy shares of American Oriental Bioengineering?

Shares of AOBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is American Oriental Bioengineering's stock price today?

One share of AOBI stock can currently be purchased for approximately $2.50.

How big of a company is American Oriental Bioengineering?

American Oriental Bioengineering has a market capitalization of $180,000.00.

How can I contact American Oriental Bioengineering?

American Oriental Bioengineering's mailing address is NO 4018 JINTIAN ROAD ANLIAN PLAZA 12F SUITE B02, SHENZHEN F4, 518026. The company can be reached via phone at 86-451-8666-6601 or via email at [email protected]

MarketBeat Community Rating for American Oriental Bioengineering (OTCMKTS AOBI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about American Oriental Bioengineering and other stocks. Vote "Outperform" if you believe AOBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AOBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel